{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:24:43Z","timestamp":1770485083082,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T00:00:00Z","timestamp":1380672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077406","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T18:23:52Z","timestamp":1380738232000},"page":"e77406","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas"],"prefix":"10.1371","volume":"8","author":[{"given":"Leonardo","family":"Vieria Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Eduardo","family":"Wildemberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Machado","family":"Colli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelma Veronica","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Barbosa","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emerson L.","family":"Gasparetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Maeda","family":"Takiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica Roberto","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"YC Patel","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"GF Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2008-1826","article-title":"Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly","volume":"94","author":"LV Neto","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","first-page":"580","article-title":"Validation of immunohistochemistry for somatostatin receptor subtype 2A in human somatotropinomas: comparison between quantitative real time RT-PCR and immunohistochemistry","volume":"35","author":"LE Wildemberg","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"ref5","first-page":"38","article-title":"Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2, expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs","volume":"36","author":"LE Wildemberg","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1210\/jc.2012-2609","article-title":"Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly","volume":"98","author":"F Gatto","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","first-page":"725","article-title":"[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil]. Arq Bras","volume":"55","author":"L Vieira Neto","year":"2011","journal-title":"Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11154-008-9107-z","article-title":"Medical therapy of pituitary adenomas: effects on tumor shrinkage","volume":"10","author":"A Colao","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ijc.24602","article-title":"Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly","volume":"125","author":"M Theodoropoulou","year":"2009","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-05-1189","article-title":"Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression","volume":"66","author":"M Theodoropoulou","year":"2006","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"HS Chahal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"MR Gadelha","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2010.01.033","article-title":"ZAC1 target genes and pituitary tumorigenesis","volume":"326","author":"M Theodoropoulou","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"ref14","first-page":"6794","article-title":"The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas","volume":"60","author":"U Pagotto","year":"2000","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2004.08.051","article-title":"Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer","volume":"95","author":"D Cvetkovic","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/sj.onc.1202933","article-title":"Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors","volume":"18","author":"B Bilanges","year":"1999","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.humpath.2006.02.002","article-title":"Frequent loss of heterozygosity at 6q in pheochromocytoma","volume":"37","author":"S Lemeta","year":"2006","journal-title":"Hum Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/nen.0b013e318149ee64","article-title":"Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma","volume":"66","author":"S Lemeta","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2011-0109","article-title":"Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors","volume":"152","author":"KA Michaelis","year":"2011","journal-title":"Endocrinology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1210\/jc.2009-0471","article-title":"Predicting recurrence of nonfunctioning pituitary adenomas","volume":"94","author":"TW Noh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","first-page":"818","article-title":"Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker","volume":"82","author":"AS Bates","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2105-10-268","article-title":"QPCR: Application for real-time PCR data management and analysis","volume":"10","author":"S Pabinger","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"C Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"L Jomori de Pinho Kasuki","year":"2011","journal-title":"Neuroendocrinology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1210\/jc.2004-1093","article-title":"Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly","volume":"90","author":"JS Bevan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","article-title":"Antitumor effects of somatostatin","volume":"286","author":"S Pyronnet","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"ref28","first-page":"1","article-title":"Regulation of Somatostatin Receptor Type 2 (SSTR2) by the Transcriptional Cofactor ZAC1","volume":"5","author":"M Theodoropoulou","year":"2012","journal-title":"J Klin Endokrinol Stoffw"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/endo.140.2.6532","article-title":"Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation","volume":"140","author":"U Pagotto","year":"1999","journal-title":"Endocrinology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/en.2002-220949","article-title":"Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities","volume":"144","author":"T Florio","year":"2003","journal-title":"Endocrinology"}],"updated-by":[{"DOI":"10.1371\/annotation\/c55f4d48-d393-4ff5-b363-c9fc85bfbd93","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:21:58Z","timestamp":1540005718000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077406"}},"subtitle":[],"editor":[{"given":"Alfredo","family":"Fusco","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,2]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077406","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/c55f4d48-d393-4ff5-b363-c9fc85bfbd93","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,2]]}}}